Results: 3

1.
Figure 1

Figure 1. From: Cost effectiveness of the type II Boston keratoprosthesis.

The type II Boston keratoprosthesis. The front plate of the keratoprosthesis is shown assembled ex vivo.

J D Ament, et al. Eye (Lond). 2011 March;25(3):342-349.
2.
Figure 2

Figure 2. From: Cost effectiveness of the type II Boston keratoprosthesis.

The clinical appearance of the type II Boston keratoprosthesis. The front plate of the keratoprosthesis is shown implanted through the eyelid of a patient with a history of Steven–Johnson's Syndrome.

J D Ament, et al. Eye (Lond). 2011 March;25(3):342-349.
3.
Figure 3

Figure 3. From: Cost effectiveness of the type II Boston keratoprosthesis.

Expected value decision tree for the type II Boston keratoprosthesis—preoperative, perioperative, and postoperative management. Decision tree is broken down into initial, inevitable, probable, and possible costs. Costs are reported on the basis of the 2010 allowable reimbursement from Medicare. Probability of occurrence is displayed below the decision/cost item. A single asterisk indicates costs that require appropriate discounting. Discounting can occur over some or all of the years being assessed in this study, depending on need and utilization of the service. Furthermore, in some instances, the cost changes after the initial year of use.

J D Ament, et al. Eye (Lond). 2011 March;25(3):342-349.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk